03873nam a22005535i 45000010014000000030009000140050017000230060019000400070015000590080041000740200018001150240031001330350021001640400033001850410008002180440015002260720023002411000076002642450095003402640047004352640011004823000031004933360026005243370026005503380036005763470024006124900065006365050340007015060104010415201282011455380049024275460016024765880112024926500027026046500035026316500028026666500056026946500045027506500065027957730114028608560061029748560049030358560080030849120079031649120016032439120017032599120019032769120024032959781478023678DE-B159720230228123812.0m|||||o||d||||||||cr || ||||||||230228t20222023ncu    fo  d z      eng d  a97814780236787 a10.1515/97814780236782doi  a(DE-B1597)649484  aDE-B1597bengcDE-B1597erda0 aeng  ancucUS-NC 7aSOC0020102bisacsh1 aHayden, Cori, eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut14aThe Spectacular Generic :bPharmaceuticals and the Simipolitical in Mexico /cCori Hayden. 1aDurham : bDuke University Press, c[2022] 4c©2023  a1 online resource (256 p.)  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aCritical Global Health: Evidence, Efficacy, Ethnography : 4700tFrontmatter -- tContents -- tPreface -- tAcknowledgments -- tIntroduction: Rx for MX: Dr. Simi’s Mexican revolution -- t1 Same and Not the Same -- t2 Simipolitics: state and not the state -- t3 No Patent, No Generic -- t4 Access, Excess -- t5 Supergeneric vs. 5 Mere Commodity -- tCoda -- tNotes -- tReferences -- tIndex0 arestricted accessuhttp://purl.org/coar/access_right/c_16ecfonline access with authorization2star  aIn The Spectacular Generic, Cori Hayden examines how generic drugs have transformed public health politics and everyday experiences of pharmaceutical consumption in Latin America. Focusing on the Mexican pharmacy chain Farmacias Similares and its proprietor, Víctor González Torres, Hayden shows how generics have become potent commodities in a postpatent world. In the early 2000s, González Torres, a.k.a. “Dr. Simi,” capitalized on the creation of new markets for generic medicines, selling cheaper copies of leading-brand drugs across Latin America. But Dr. Simi has not simply competed with the transnationals; his enterprise has also come to compete with the Mexican state, reorganizing the provision of medicine and basic health care for millions of people. Hayden juxtaposes this story with Dr. Simi’s less successful efforts in Argentina, where he confronted a radically different configuration of pharmaceutical politics. Building from these diverging trajectories, Hayden illuminates the politics of generic substitution as a question that goes beyond substituting one drug for another. Generic politics can radically reshape the relations among consumers, states, and pharmaceutical markets, even as they have yet to resolve the problems of cost and access.  aMode of access: Internet via World Wide Web.  aIn English.0 aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 28. Feb 2023) 0aGeneric drugszMexico. 0aMedical policyzLatin America. 0aMedical policyzMexico. 0aPharmaceutical industryxPolitical aspectszMexico. 0aPublic healthxEconomic aspectszMexico. 7aSOCIAL SCIENCE / Anthropology / Cultural & Social.2bisacsh08iTitle is part of eBook package:dDe GruytertDuke University Press Complete eBook-Package 2023z978311099775040uhttps://doi.org/10.1515/9781478023678?locatt=mode:legacy40uhttps://www.degruyter.com/isbn/9781478023678423Coveruhttps://www.degruyter.com/document/cover/isbn/9781478023678/original  a978-3-11-099775-0  Duke University Press Complete eBook-Package 2023b2023  aEBA_DUK_ALL  aEBA_DUK_EALL  aEBA_DUK_SSHALL  aGBV-deGruyter-alles